| 製品番号 |
製品名 |
製品効果
|
純度 |
Rare Diseases
|
| HY-138625 |
PXS-5505 free base |
Inhibitor |
99.97% |
Unkown |
| HY-101771A |
(2-Chloropyridin-4-yl)methanamine hydrochloride |
|
99.70% |
Unkown |
| HY-138625A |
PXS-5505 anhydrous |
Inhibitor |
99.90% |
Unkown |
| HY-114286A |
PXS-5153A monohydrochloride |
Inhibitor |
99.59% |
Unkown |
| HY-170538 |
SNT-5382 |
Inhibitor |
99.96% |
Unkown |
| HY-151499A |
PXS-6302 hydrochloride |
Inhibitor |
99.57% |
Unkown |
| HY-N0554 |
Escin IA |
Inhibitor |
99.59% |
Unkown |
| HY-151498A |
PXS-4787 hydrochloride |
Inhibitor |
99.71% |
Unkown |
| HY-171955 |
LXG6403 |
|
99.85% |
Unkown |
| HY-170573A |
LOXL2-IN-1 tosylate |
Inhibitor |
99.90% |
Unkown |
| HY-130242 |
PXS-5120A |
|
98.12% |
Unkown |
| HY-114286 |
PXS-5153A |
Inhibitor |
/ |
Unkown |
| HY-151498 |
PXS-4787 |
Inhibitor |
/ |
Unkown |
| HY-151499 |
PXS-6302 |
Inhibitor |
/ |
Unkown |
| HY-RS16627 |
Loxl2 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-138625B |
PXS-5505 |
Inhibitor |
/ |
Unkown |
| HY-170573 |
LOXL2-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-180581 |
LOXL2/sGC modulator-1 |
|
/ |
Unkown |
| HY-180585 |
LOXL2/sGC modulator-2 |
|
/ |
Unkown |
| HY-183644 |
LNO 9 |
Inhibitor |
/ |
Unkown |
| HY-RS07742 |
LOXL2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS21632 |
Loxl3 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS23062 |
Loxl2 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W036566 |
2-Phenylcyclopropanamine |
Inhibitor |
/ |
Unkown |